Literature DB >> 18326703

Astigmatism associated with experimentally induced myopia or hyperopia in chickens.

Chea-Su Kee1, Li Deng.   

Abstract

PURPOSE: Astigmatism is a very common refractive error in humans, but its etiology is poorly understood. The primary purpose of this study was to determine whether alterations in visual experience would result in astigmatism in chicks.
METHODS: Longitudinal and cross-sectional data were obtained from chicks that were raised undergoing four different visual manipulations known to alter axial eye growth: form deprivation by translucent occluders, spherical defocus by -10- or +10-D lenses, and constant light. The visual manipulations began at 5 days of age and continued for a week. Age-matched groups raised without any treatment or with Velcro rings or plano lenses served as control groups. Refractions in all birds were measured with a Hartinger refractometer, and infrared photokeratometry was performed in a subset of birds at the end of the treatment period.
RESULTS: In control birds, natural astigmatism decreased in magnitude over the 7-day treatment period. In contrast, birds treated with visual manipulations developed significant amounts of astigmatism throughout the treatment period. At the end of the 7-day treatment period, whereas only 8.6% of the control chicks had refractive astigmatism >1 D, the percentage of treated birds that had astigmatism >1 D in each treatment group ranged from 66.7% to 100%. The astigmatism in the treated eyes was predominantly against-the-rule, corneal in nature, and correlated significantly with spherical ametropia of the principal meridians.
CONCLUSIONS: Visual manipulations known to induce axial ametropia also promote the genesis of astigmatism in chickens. The characteristics of astigmatism associated with spherical myopia or hyperopia in chicks is similar to those reported in humans in many respects, supporting the hypothesis that vision-dependent changes in eye growth may contribute to the astigmatism commonly found in humans.

Entities:  

Mesh:

Year:  2008        PMID: 18326703     DOI: 10.1167/iovs.06-1370

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  11 in total

Review 1.  IMI - Report on Experimental Models of Emmetropization and Myopia.

Authors:  David Troilo; Earl L Smith; Debora L Nickla; Regan Ashby; Andrei V Tkatchenko; Lisa A Ostrin; Timothy J Gawne; Machelle T Pardue; Jody A Summers; Chea-Su Kee; Falk Schroedl; Siegfried Wahl; Lyndon Jones
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-02-28       Impact factor: 4.799

2.  Prevalence of correctable visual impairment in primary school children in Qassim Province, Saudi Arabia.

Authors:  Yousef H Aldebasi
Journal:  J Optom       Date:  2014-03-11

3.  Anisometropia in children from infancy to 15 years.

Authors:  Li Deng; Jane E Gwiazda
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-20       Impact factor: 4.799

4.  Biophysical properties of corneal cells reflect high myopia progression.

Authors:  Ying Xin; Byung Soo Kang; Yong-Ping Zheng; Sze Wan Shan; Chea-Su Kee; Youhua Tan
Journal:  Biophys J       Date:  2021-05-20       Impact factor: 3.699

5.  Effects of optically imposed astigmatism on early eye growth in chicks.

Authors:  Chin Hung Geoffrey Chu; Chea Su Kee
Journal:  PLoS One       Date:  2015-02-12       Impact factor: 3.240

6.  Genome-wide association study for refractive astigmatism reveals genetic co-determination with spherical equivalent refractive error: the CREAM consortium.

Authors:  Qing Li; Robert Wojciechowski; Claire L Simpson; Pirro G Hysi; Virginie J M Verhoeven; Mohammad Kamran Ikram; René Höhn; Veronique Vitart; Alex W Hewitt; Konrad Oexle; Kari-Matti Mäkelä; Stuart MacGregor; Mario Pirastu; Qiao Fan; Ching-Yu Cheng; Beaté St Pourcain; George McMahon; John P Kemp; Kate Northstone; Jugnoo S Rahi; Phillippa M Cumberland; Nicholas G Martin; Paul G Sanfilippo; Yi Lu; Ya Xing Wang; Caroline Hayward; Ozren Polašek; Harry Campbell; Goran Bencic; Alan F Wright; Juho Wedenoja; Tanja Zeller; Arne Schillert; Alireza Mirshahi; Karl Lackner; Shea Ping Yip; Maurice K H Yap; Janina S Ried; Christian Gieger; Federico Murgia; James F Wilson; Brian Fleck; Seyhan Yazar; Johannes R Vingerling; Albert Hofman; André Uitterlinden; Fernando Rivadeneira; Najaf Amin; Lennart Karssen; Ben A Oostra; Xin Zhou; Yik-Ying Teo; E Shyong Tai; Eranga Vithana; Veluchamy Barathi; Yingfeng Zheng; Rosalynn Grace Siantar; Kumari Neelam; Youchan Shin; Janice Lam; Ekaterina Yonova-Doing; Cristina Venturini; S Mohsen Hosseini; Hoi-Suen Wong; Terho Lehtimäki; Mika Kähönen; Olli Raitakari; Nicholas J Timpson; David M Evans; Chiea-Chuen Khor; Tin Aung; Terri L Young; Paul Mitchell; Barbara Klein; Cornelia M van Duijn; Thomas Meitinger; Jost B Jonas; Paul N Baird; David A Mackey; Tien Yin Wong; Seang-Mei Saw; Olavi Pärssinen; Dwight Stambolian; Christopher J Hammond; Caroline C W Klaver; Cathy Williams; Andrew D Paterson; Joan E Bailey-Wilson; Jeremy A Guggenheim
Journal:  Hum Genet       Date:  2014-11-04       Impact factor: 4.132

7.  Internal Astigmatism and Its Role in the Growth of Axial Length in School-Age Children.

Authors:  Liangcheng Wu; Chenghai Weng; Fei Xia; Xiaoying Wang; Xingtao Zhou
Journal:  J Ophthalmol       Date:  2018-04-18       Impact factor: 1.909

8.  High myopia induced by form deprivation is associated with altered corneal biomechanical properties in chicks.

Authors:  Byung Soo Kang; Li-Ke Wang; Yong-Ping Zheng; Jeremy A Guggenheim; William K Stell; Chea-Su Kee
Journal:  PLoS One       Date:  2018-11-12       Impact factor: 3.240

9.  Early Astigmatism Can Alter Myopia Development in Chickens.

Authors:  Sonal Aswin Vyas; Chea-Su Kee
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-02-01       Impact factor: 4.799

10.  Region-specific differential corneal and scleral mRNA expressions of MMP2, TIMP2, and TGFB2 in highly myopic-astigmatic chicks.

Authors:  Lisa Yan-Yan Xi; Shea Ping Yip; Sze Wan Shan; Jody Summers-Rada; Chea-Su Kee
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.